M3, Inc. (MTHRY)

OTCMKTS · Delayed Price · Currency is USD
6.70
-0.45 (-6.29%)
Nov 6, 2025, 3:58 PM EST
-6.29%
Market Cap9.20B
Revenue (ttm)2.13B
Net Income (ttm)286.05M
Shares Outn/a
EPS (ttm)0.42
PE Ratio32.16
Forward PEn/a
Dividend0.14 (1.96%)
Ex-Dividend DateMar 28, 2025
Volume36,487
Average Volume246,440
Open6.76
Previous Close7.15
Day's Range6.70 - 7.00
52-Week Range4.01 - 8.35
Beta0.92
RSI35.95
Earnings DateNov 12, 2025

About M3, Inc.

M3, Inc. provides medical-related services to physicians and other healthcare professionals through the internet. It operates m3.com, a members-only website for providing information, tools, and services for medical professionals; MR-kun which delivers the latest medical information for daily medical practice; QOL-kun, a marketing support service that provides selected information useful for doctors; m3.com CAREER, a physician recruitment and career change support site; and Drug Carrier, a job information site for pharmacists. The company also ... [Read more]

Sector Healthcare
Founded 2000
Employees 15,360
Stock Exchange OTCMKTS
Ticker Symbol MTHRY
Full Company Profile

Financial Performance

In 2024, M3, Inc.'s revenue was 284.90 billion, an increase of 19.26% compared to the previous year's 238.88 billion. Earnings were 40.48 billion, a decrease of -10.57%.

Financial numbers in JPY Financial Statements

News

M3, Inc.: Stand-Out Success Story Of Japanese Internet

M3 was a clear beneficiary of the pandemic which has accelerated digitization of pharmaceuticals marketing on its online platform business.

4 years ago - Seeking Alpha

5 Health Care Stocks Growing Fast

Investors may be interested in the following health care companies, as they have expanded their revenue per share and Ebitda per share by more than 10% over the trailing five-year and 10-year periods ...

4 years ago - GuruFocus

5 Telehealth Stocks for Long-Term Financial Fitness

There are no silver linings to the pandemic. Nevertheless, some stocks and sectors have benefited greatly from the societal changes COVID-19 has wrought.

5 years ago - Kiplinger